Delayed
Saudi Arabian S.E.
04:42:34 2024-05-26 am EDT
|
5-day change
|
1st Jan Change
|
278.8
SAR
|
-1.83%
|
|
-6.06%
|
-1.76%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
38,150
|
56,490
|
77,210
|
99,400
|
99,400
|
-
|
-
|
Enterprise Value (EV)
1 |
38,150
|
56,609
|
77,663
|
101,963
|
105,243
|
105,316
|
106,516
|
P/E ratio
|
36.1
x
|
41.1
x
|
46.7
x
|
48.5
x
|
44.5
x
|
36.3
x
|
30.1
x
|
Yield
|
1.38%
|
1.67%
|
-
|
-
|
1.53%
|
1.76%
|
2.02%
|
Capitalization / Revenue
|
6.51
x
|
7.79
x
|
9.29
x
|
10.5
x
|
8.64
x
|
6.69
x
|
6.03
x
|
EV / Revenue
|
6.51
x
|
7.81
x
|
9.34
x
|
10.7
x
|
9.14
x
|
7.09
x
|
6.46
x
|
EV / EBITDA
|
26.6
x
|
31.8
x
|
38.6
x
|
42.3
x
|
35.9
x
|
29.3
x
|
25
x
|
EV / FCF
|
26.9
x
|
60.9
x
|
58.4
x
|
-403
x
|
-138
x
|
61.2
x
|
42.4
x
|
FCF Yield
|
3.72%
|
1.64%
|
1.71%
|
-0.25%
|
-0.73%
|
1.63%
|
2.36%
|
Price to Book
|
7.77
x
|
10.6
x
|
13.1
x
|
15.3
x
|
13.5
x
|
12.3
x
|
10.3
x
|
Nbr of stocks (in thousands)
|
350,000
|
350,000
|
350,000
|
350,000
|
350,000
|
-
|
-
|
Reference price
2 |
109.0
|
161.4
|
220.6
|
284.0
|
284.0
|
284.0
|
284.0
|
Announcement Date
|
2/21/21
|
2/20/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,862
|
7,250
|
8,311
|
9,508
|
11,511
|
14,857
|
16,481
|
EBITDA
1 |
1,433
|
1,781
|
2,010
|
2,408
|
2,934
|
3,591
|
4,260
|
EBIT
1 |
1,115
|
1,466
|
1,700
|
2,096
|
2,382
|
3,000
|
3,618
|
Operating Margin
|
19.02%
|
20.22%
|
20.46%
|
22.04%
|
20.69%
|
20.19%
|
21.95%
|
Earnings before Tax (EBT)
1 |
1,128
|
1,491
|
1,797
|
2,170
|
2,434
|
3,038
|
3,786
|
Net income
1 |
1,055
|
1,377
|
1,651
|
2,046
|
2,230
|
2,800
|
3,340
|
Net margin
|
18.01%
|
18.99%
|
19.86%
|
21.52%
|
19.37%
|
18.85%
|
20.27%
|
EPS
2 |
3.020
|
3.930
|
4.720
|
5.850
|
6.380
|
7.815
|
9.450
|
Free Cash Flow
1 |
1,420
|
929.3
|
1,330
|
-252.7
|
-763.3
|
1,720
|
2,510
|
FCF margin
|
24.23%
|
12.82%
|
16.01%
|
-2.66%
|
-6.63%
|
11.58%
|
15.23%
|
FCF Conversion (EBITDA)
|
99.14%
|
52.18%
|
66.19%
|
-
|
-
|
47.9%
|
58.93%
|
FCF Conversion (Net income)
|
134.57%
|
67.5%
|
80.59%
|
-
|
-
|
61.44%
|
75.15%
|
Dividend per Share
2 |
1.500
|
2.700
|
-
|
-
|
4.351
|
4.992
|
5.729
|
Announcement Date
|
2/21/21
|
2/20/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
1,968
|
1,991
|
2,014
|
2,052
|
2,254
|
2,307
|
2,272
|
2,443
|
2,486
|
2,521
|
EBITDA
|
-
|
498.7
|
-
|
-
|
505.3
|
-
|
577
|
-
|
-
|
-
|
EBIT
1 |
396.3
|
422.1
|
414.7
|
436.1
|
427.6
|
510.6
|
498.8
|
552.1
|
534.2
|
556.1
|
Operating Margin
|
20.13%
|
21.2%
|
20.59%
|
21.25%
|
18.97%
|
22.13%
|
21.95%
|
22.6%
|
21.48%
|
22.05%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
383.6
|
390.5
|
398.1
|
420.6
|
441.5
|
489.3
|
487
|
544.8
|
491
|
551
|
Net margin
|
19.49%
|
19.61%
|
19.77%
|
20.5%
|
19.59%
|
21.21%
|
21.43%
|
22.3%
|
19.75%
|
21.85%
|
EPS
2 |
1.090
|
-
|
-
|
1.200
|
1.260
|
1.400
|
1.390
|
1.560
|
1.500
|
1.570
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/22
|
4/24/22
|
8/7/22
|
10/23/22
|
2/21/23
|
5/7/23
|
8/6/23
|
10/30/23
|
2/20/24
|
4/28/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
119
|
453
|
2,563
|
5,843
|
5,916
|
7,116
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.0667
x
|
0.2255
x
|
1.064
x
|
1.991
x
|
1.647
x
|
1.67
x
|
Free Cash Flow
1 |
1,420
|
929
|
1,330
|
-253
|
-763
|
1,720
|
2,510
|
ROE (net income / shareholders' equity)
|
22.7%
|
26.9%
|
29.4%
|
33.1%
|
32.1%
|
35.7%
|
37.1%
|
ROA (Net income/ Total Assets)
|
11.8%
|
13.6%
|
14.1%
|
14.4%
|
13.1%
|
15.5%
|
15.9%
|
Assets
1 |
8,974
|
10,154
|
11,706
|
14,191
|
17,017
|
18,070
|
20,981
|
Book Value Per Share
2 |
14.00
|
15.30
|
16.80
|
18.50
|
21.00
|
23.10
|
27.40
|
Cash Flow per Share
2 |
-
|
-
|
-
|
9.270
|
7.200
|
8.700
|
11.10
|
Capex
1 |
758
|
1,254
|
1,513
|
3,497
|
3,472
|
2,148
|
1,798
|
Capex / Sales
|
12.93%
|
17.29%
|
18.21%
|
36.78%
|
30.17%
|
14.46%
|
10.91%
|
Announcement Date
|
2/21/21
|
2/20/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Average target price
284
SAR Spread / Average Target 0.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.76% | 26.5B | | +17.74% | 83.47B | | -29.66% | 69.72B | | +3.06% | 17.69B | | -12.16% | 16.83B | | +2.47% | 15.7B | | +74.82% | 13.45B | | +73.52% | 12.81B | | +0.76% | 12.69B | | +2.74% | 12.42B |
Other Healthcare Facilities & Services
|